A prospective study to assess the impact of a novel CFTR therapy combination on body composition in patients with cystic fibrosis with F508del mutation
Author:
Publisher
Elsevier BV
Subject
Critical Care and Intensive Care Medicine,Nutrition and Dietetics
Reference27 articles.
1. Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial;Heijerman;Lancet,2019
2. Effect of CFTR modulators on anthropometric parameters in individuals with cystic fibrosis: an evidence analysis center systematic review;Bailey;J Acad Nutr Diet [Internet],2021
3. State of the art on approved cystic fibrosis transmembrane conductance regulator (Cftr) modulators and triple-combination therapy;Meoli;Pharmaceuticals,2021
4. Body composition in individuals with cystic fibrosis;Soltman;J Clin Transl Endocrinol [Internet,2021
5. Body composition and pulmonary function in cystic fibrosis;Sheikh;Front Pediatr,2014
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Impact of CFTR modulator therapy on body composition as assessed by thoracic computed tomography: A follow-up study;Nutrition;2024-07
2. Evolution of nutritional management in children with cystic fibrosis – a narrative review;Journal of Human Nutrition and Dietetics;2024-04-25
3. Nutritional support for adult сystic fibrosis patients receiving targeted treatment;PULMONOLOGIYA;2024-03-14
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3